Article
Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.
Pharmacogenetics - 1 Jan 1995
Kato S, Onda M, Matsukura N, Tokunaga A, Tajiri T, Kim D Y, Tsuruta H, Matsuda N, Yamashita K, Shields P G
Abstract excerpt
Cytochrome P4502E1 (CYP2E1) activates carcinogenic N-nitrosamines, benzene, urethane and other low molecular weight compounds. This enzyme is also inducible by ethanol, and metabolizes alcohol. A restriction fragment length polymorphism (RFLP) using the Rsa I restriction enzyme has been identified in the CYP2E1 transcription regulatory region; recent studies suggest that this polymorphism may affect gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
